These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 6201533)

  • 1. LFA-1, LFA-2, and LFA-3 antigens are involved in CTL-target conjugation.
    Krensky AM; Robbins E; Springer TA; Burakoff SJ
    J Immunol; 1984 May; 132(5):2180-2. PubMed ID: 6201533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human lymphocyte function associated antigen-1 (LFA-1): identification of multiple antigenic epitopes and their relationship to CTL-mediated cytotoxicity.
    Ware CF; Sanchez-Madrid F; Krensky AM; Burakoff SJ; Strominger JL; Springer TA
    J Immunol; 1983 Sep; 131(3):1182-8. PubMed ID: 6193178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The functional significance, distribution, and structure of LFA-1, LFA-2, and LFA-3: cell surface antigens associated with CTL-target interactions.
    Krensky AM; Sanchez-Madrid F; Robbins E; Nagy JA; Springer TA; Burakoff SJ
    J Immunol; 1983 Aug; 131(2):611-6. PubMed ID: 6345670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T3 monoclonal antibody activation of nonspecific cytolysis: a mechanism of CTL inhibition.
    Mentzer SJ; Barbosa JA; Burakoff SJ
    J Immunol; 1985 Jul; 135(1):34-8. PubMed ID: 2582036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility of cytotoxic T lymphocyte (CTL) clones to inhibition by anti-T3 and anti-T4 (but not anti-LFA-1) monoclonal antibodies varies with the "avidity" of CTL-target interaction.
    Shaw S; Goldstein G; Springer TA; Biddison WE
    J Immunol; 1985 May; 134(5):3019-26. PubMed ID: 2580011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Membrane glycoprotein p150,95 of human cytotoxic T cell clone is involved in conjugate formation with target cells.
    Keizer GD; Borst J; Visser W; Schwarting R; de Vries JE; Figdor CG
    J Immunol; 1987 May; 138(10):3130-6. PubMed ID: 3106475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blocking of CTL-mediated killing by monoclonal antibodies to LFA-1 and Lyt-2, 3. II. Evidence that trypsin pretreatment of target cells removes a non-H-2 molecule important in killing.
    Gromkowski SH; Heagy W; Martz E
    J Immunol; 1985 Jan; 134(1):70-7. PubMed ID: 3880579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CTL adhesion and antigen recognition are discrete steps in the human CTL-target cell interaction.
    Mentzer SJ; Smith BR; Barbosa JA; Crimmins MA; Herrmann SH; Burakoff SJ
    J Immunol; 1987 Mar; 138(5):1325-30. PubMed ID: 3543126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human cytolytic T lymphocyte interactions with vascular endothelium and fibroblasts: role of effector and target cell molecules.
    Collins T; Krensky AM; Clayberger C; Fiers W; Gimbrone MA; Burakoff SJ; Pober JS
    J Immunol; 1984 Oct; 133(4):1878-84. PubMed ID: 6432903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene mapping and somatic cell hybrid analysis of the role of human lymphocyte function-associated antigen-3 (LFA-3) in CTL-target cell interactions.
    Barbosa JA; Mentzer SJ; Kamarck ME; Hart J; Biro PA; Strominger JL; Burakoff SJ
    J Immunol; 1986 Apr; 136(8):3085-91. PubMed ID: 3514752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recognition of HLA-A2 mutant and variant target cells by an HLA-A2 allospecific human cytotoxic T lymphocyte line.
    Ware CF; Krangel MS; Pious D; Burakoff SJ; Strominger JL
    J Immunol; 1983 Sep; 131(3):1312-7. PubMed ID: 6193184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for a regulatory role of the T8 (CD8) antigen in antigen-specific and anti-T3-(CD3)-induced lytic activity of allospecific cytotoxic T lymphocyte clones.
    Van Seventer GA; Van Lier RA; Spits H; Ivanyi P; Melief CJ
    Eur J Immunol; 1986 Nov; 16(11):1363-71. PubMed ID: 2430810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxic T cells directed against HLA-DR antigens and their surface proteins.
    Burakoff SJ; Clayberger C; Hemler M; Krensky AM; Reiss CS; Robbins E; Sanchez-Madrid F; Springer TA; Strominger JL; Ware CF
    Diagn Immunol; 1983; 1(3):116-9. PubMed ID: 6238749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human allospecific cytolytic T lymphocyte lysis of a murine cell transfected with HLA-A2.
    Koller TD; Clayberger C; Maryanski JL; Krensky AM
    J Immunol; 1987 Apr; 138(7):2044-9. PubMed ID: 3549894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of the T cell receptor, CD8, and LFA-1 in different stages of the cytolytic reaction mediated by alloreactive T lymphocyte clones.
    Blanchard D; van Els C; Borst J; Carrel S; Boylston A; de Vries JE; Spits H
    J Immunol; 1987 Apr; 138(8):2417-21. PubMed ID: 3104466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional distinctions between the LFA-1, LFA-2, and LFA-3 membrane proteins on human CTL are revealed with trypsin-pretreated target cells.
    Gromkowski SH; Krensky AM; Martz E; Burakoff SJ
    J Immunol; 1985 Jan; 134(1):244-9. PubMed ID: 3871102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of monoclonal antibodies to the alpha and beta chains of the human lymphocyte function-associated (H-LFA-1) antigen on T lymphocyte functions.
    Dongworth DW; Gotch FM; Hildreth JE; Morris A; McMichael AJ
    Eur J Immunol; 1985 Sep; 15(9):888-92. PubMed ID: 3930261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heritable lymphocyte function-associated antigen-1 deficiency: abnormalities of cytotoxicity and proliferation associated with abnormal expression of LFA-1.
    Krensky AM; Mentzer SJ; Clayberger C; Anderson DC; Schmalstieg FC; Burakoff SJ; Springer TA
    J Immunol; 1985 Nov; 135(5):3102-8. PubMed ID: 3900204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Species-restricted recognition of transfected HLA-A2 and HLA-B7 by human CTL clones.
    Mentzer SJ; Barbosa JA; Strominger JL; Biro PA; Burakoff SJ
    J Immunol; 1986 Jul; 137(2):408-13. PubMed ID: 3088100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A murine very late activation antigen-like extracellular matrix receptor involved in CD2- and lymphocyte function-associated antigen-1-independent killer-target cell interaction.
    Takahashi K; Nakamura T; Koyanagi M; Kato K; Hashimoto Y; Yagita H; Okumura K
    J Immunol; 1990 Dec; 145(12):4371-9. PubMed ID: 1979586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.